Literature DB >> 22820103

Starting and staying on preventive medication for cardiovascular disease.

Nicola Gale1, Tom Marshall, George Bramley.   

Abstract

PURPOSE OF REVIEW: To synthesize the qualitative research literature regarding medication use to prevent cardiovascular disease in order to explain the variation in healthcare professional (HCP) and patient behaviours, and to evaluate the implications for practice. RECENT
FINDINGS: The decision to start preventive medication is affected by the patient-HCP relationship and by the design of the service. Both HCPs and patients are influenced by their understanding of the evidence regarding the value of preventive interventions; their values and preferences; and their sociopolitical context and the organizational structure of their practice environment. The design of their service affects uptake as a consequence of its impact on clinical communication and the extent to which the service is tailored to the needs of the local community. Continuing to take prescribed medication is affected by both contextual and practical factors. Recommendations for practice can be split into those with a clinical focus and those with a patient or community focus. More sophisticated analyses have moved beyond recommendations for patient and HCP education, and address constraints in the organization of clinical services and the social context of evidence translation.
SUMMARY: Qualitative health research provides important insights into the experience of and context for decision making about medication prescription and adherence that can help efforts to prevent cardiovascular disease.

Entities:  

Mesh:

Year:  2012        PMID: 22820103     DOI: 10.1097/HCO.0b013e328356dae5

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  5 in total

Review 1.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

Review 2.  Patients' expectations of medicines--a review and qualitative synthesis.

Authors:  Ulrica Dohnhammar; Joanne Reeve; Tom Walley
Journal:  Health Expect       Date:  2015-02-01       Impact factor: 3.377

3.  Appraising hospital performance by using the JCHAO/CMS quality measures in Southern Italy.

Authors:  Domenico Flotta; Paolo Rizza; Pierluigi Coscarelli; Claudia Pileggi; Carmelo G A Nobile; Maria Pavia
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

4.  Patients' and health professionals' attitudes and perceptions towards the initiation of preventive drugs for primary prevention of cardiovascular disease: protocol for a systematic review of qualitative studies.

Authors:  Olla Qadi; Tom Marshall; Nicola Adderley; Danai Bem
Journal:  BMJ Open       Date:  2019-04-11       Impact factor: 2.692

5.  Patients' and health professionals' attitudes and perceptions towards the initiation of preventive drugs for primary prevention of cardiovascular disease: a systematic review of qualitative studies.

Authors:  Olla Qadi; Nakawala Lufumpa; Nicola Adderley; Danai Bem; Tom Marshall; Farina Kokab
Journal:  BJGP Open       Date:  2020-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.